Cargando…

Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate

3-bromopuryvate (3-BP) is a compound with unique antitumor activity. It has a selective action against tumor cells that exhibit the Warburg effect. It has been proven that the action of 3-BP is pleiotropic: it acts on proteins, glycolytic enzymes, reduces the amount of ATP, induces the formation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cal, Magdalena, Matyjaszczyk, Irwin, Filik, Karolina, Ogórek, Rafał, Ko, Young, Ułaszewski, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235118/ https://www.ncbi.nlm.nih.gov/pubmed/34205737 http://dx.doi.org/10.3390/ijms22126640

Ejemplares similares

The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
por: Cal, Magdalena, et al.
Publicado: (2020)

Transport of 3-bromopyruvate across the human erythrocyte membrane
por: Sadowska-Bartosz, Izabela, et al.
Publicado: (2014)

Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016)

The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016)

Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
por: Niedźwiecka, Katarzyna, et al.
Publicado: (2016)

The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells
por: Petricciuolo, Maya, et al.
Publicado: (2020)

A Culture-Based ID of Micromycetes on the Wing Membranes of Greater Mouse-Eared Bats (Myotis myotis) from the “Nietoperek” Site (Poland)
por: Ogórek, Rafał, et al.
Publicado: (2020)

First Speleomycological Study on the Occurrence of Psychrophilic and Psychrotolerant Aeromycota in the Brestovská Cave (Western Tatras Mts., Slovakia) and First Reports for Some Species at Underground Sites
por: Ogórek, Rafał, et al.
Publicado: (2021)

φYeO3-12 phage tail fiber Gp17 as a promising high specific tool for recognition of Yersinia enterocolitica pathogenic serotype O:3
por: Filik, Karolina, et al.
Publicado: (2022)

In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains
por: Krzyżek, Paweł, et al.
Publicado: (2019)

3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
por: Jagielski, Tomasz, et al.
Publicado: (2018)

Plant–Fungal Interactions: A Case Study of Epicoccoum nigrum Link
por: Ogórek, Rafał, et al.
Publicado: (2020)

Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies
por: Yadav, Saveg, et al.
Publicado: (2017)

Construction and Evaluation of Folic Acid-Modified 3-Bromopyruvate Cubosomes
por: Hou, Fangyan, et al.
Publicado: (2020)

In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes
por: Xin, Qi, et al.
Publicado: (2019)

Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
por: El Sayed, Salah Mohamed
Publicado: (2018)

Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells
por: Rodrigues, Ana Sofia, et al.
Publicado: (2015)

Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
por: Sun, Yiming, et al.
Publicado: (2015)

Targeting Cancer Cells using 3-bromopyruvate for Selective Cancer Treatment
por: Baghdadi, Hussam H.
Publicado: (2017)

Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
por: Pieńkowska, Natalia, et al.
Publicado: (2021)

3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
por: Vital, Patrik da Silva, et al.
Publicado: (2022)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis
por: Nikravesh, Hojatolla, et al.
Publicado: (2021)

The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate
por: Marrache, Sean, et al.
Publicado: (2015)

Crosstalk between anticancer drugs and mitochondrial functions
por: Sahu, Kuleshwar, et al.
Publicado: (2021)

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019)

Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
por: Attia, Yasmin M., et al.
Publicado: (2015)

Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy
por: Gan, Lei, et al.
Publicado: (2020)

Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
por: Nilsson, H, et al.
Publicado: (2015)

The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
por: Davidescu, Magdalena, et al.
Publicado: (2015)

Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model
por: Kunjithapatham, Rani, et al.
Publicado: (2013)

Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate
por: Yadav, Saveg, et al.
Publicado: (2019)

Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
por: Fan, Tengjiao, et al.
Publicado: (2019)

Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients
por: Faria, Alessandra V. S., et al.
Publicado: (2019)

Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells
por: Sun, Yiming, et al.
Publicado: (2021)

Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against Echinococcus multilocularis protoscoleces
por: Kouguchi, Hirokazu, et al.
Publicado: (2022)

The Presence of Mycotoxins in Human Amniotic Fluid
por: Gromadzka, Karolina, et al.
Publicado: (2021)

Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis
por: Gandham, Srujan Kumar, et al.
Publicado: (2015)

The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression
por: Ho, Nelson, et al.
Publicado: (2016)

3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis
por: XIAN, SHU-LIN, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_clg70rtnmm7ecauchoggh68fdb